Abeona Therapeutics Inc.ABEONASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +1275.86% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +1369.52% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +989.47% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +1121.43% | +0.00% |
| Weighted Average Shares Growth | +93.89% | +60.62% | +82.23% | +31.28% | +12.81% |
| Weighted Average Shares Diluted Growth | +93.89% | +60.62% | +82.23% | +30.09% | +12.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -26.98% | -32.41% | -27.55% | -0.61% | +0.19% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +82.47% | +70.20% | +32.79% | +83.75% | +91.63% |
| Book Value per Share Growth | +7.12% | +84.90% | +0.00% | +70.13% | +231.60% |
| Debt Growth | +305.99% | +326.81% | +3.49% | +3.93% | +4.32% |
| R&D Expense Growth | +25.08% | +21.89% | +37.94% | -35.53% | -52.85% |
| SG&A Expenses Growth | +54.09% | +35.09% | +37.39% | +98.35% | +201.59% |